Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301405 · ClinicalTrials.gov registry record · Phase 2
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
A Phase 2 study, sponsored by Kenneth Peters, MD.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00301405 is a Phase 2 study that was terminated before completion, run by Kenneth Peters, MD. The registered enrollment target is 9 participants.
The verdict
NCT00301405, a Phase 2 study, was terminated before completion, sponsored by Kenneth Peters, MD.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00301405
The ClinicalTrials.gov registry entry for NCT00301405 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kenneth Peters, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT00301405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00301405 about?
NCT00301405 is a clinical study titled "Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain". To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
What is the current status of trial NCT00301405?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2006-03. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00301405?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT00301405?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.